August 11, 2020
PAR-18-563 - NIH StrokeNet Small Business Innovation Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U44 - Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is to inform interested applicants of a change to the Key Dates for PAR-18-563 "NIH StrokeNet Small Business Innovation Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U44 - Clinical Trial Optional)". This Funding Opportunity Announcement has been extended by one additional council round. The dates have been modified to add the following New Application Due Date: April 5, 2021. Changes to the FOA are shown below in bold italics.
Currently Reads:
Part 1. Overview Information
Key Dates
Application Due Date(s) |
Standard dates apply , by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
Scientific Merit Review | Standard dates apply |
Advisory Council Review | Standard dates apply |
Earliest Start Date | Standard dates apply |
Expiration Date | January 6, 2021 |
Modified to Read:
Part 1. Overview Information
Key Dates
Application Due Date(s) |
Standard dates apply , by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
Scientific Merit Review | Standard dates apply |
Advisory Council Review | Standard dates apply |
Earliest Start Date | Standard dates apply |
Expiration Date | April 6, 2021 |
All other aspects of this FOA remain unchanged.
Claudia Scala Moy, Ph.D.
National Institute of Neurological Disorders & Stroke (NINDS)
Telephone: 301-496-9135
Email: [email protected]